Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support: A Case Series.

Szczegóły
Abstrakt

Tytuł:: Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support: A Case Series.
Autorzy:: Douglass KM; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
Strobel KM; Division of Neonatology, Department of Pediatrics, University of California, Los Angeles.
Richley M; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
Mok T; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
de St Maurice A; Division of Infectious Disease, Department of Pediatrics, University of California, Los Angeles.
Fajardo V; Division of Neonatology, Department of Pediatrics, University of California, Los Angeles.
Young AT; Division of Critical Care, Department of Anesthesia, University of California, Los Angeles.
Rao R; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
Lee L; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
Benharash P; Divison of Cardiac Surgery, Department of Surgery, University of California, Los Angeles.
Chu A; Division of Neonatology, Department of Pediatrics, University of California, Los Angeles.
Afshar Y; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles.
Źródło:: American journal of perinatology [Am J Perinatol] 2021 Jan; Vol. 38 (1), pp. 82-87. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji:: Case Reports; Journal Article
Język:: English
Imprint Name(s):: Original Publication: New York, NY : Thieme-Stratton, 1983-
MeSH Terms:: COVID-19*/complications
COVID-19*/diagnosis
COVID-19*/physiopathology
Extracorporeal Membrane Oxygenation*/adverse effects
Extracorporeal Membrane Oxygenation*/methods
Pregnancy Complications, Infectious*/diagnosis
Pregnancy Complications, Infectious*/physiopathology
Pregnancy Complications, Infectious*/therapy
Respiratory Distress Syndrome*/physiopathology
Respiratory Distress Syndrome*/therapy
Respiratory Distress Syndrome*/virology
COVID-19 Drug Treatment*
Respiration, Artificial/*methods
SARS-CoV-2/*isolation & purification
Adult ; Cesarean Section/methods ; Critical Care/methods ; Female ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical/prevention & control ; Obesity/diagnosis ; Pregnancy ; Pregnancy Outcome ; Risk Adjustment/methods ; Treatment Outcome
References:: ASAIO J. 2015 Jan-Feb;61(1):110-4. (PMID: 25248040)
Intensive Care Med. 2011 Apr;37(4):648-54. (PMID: 21318437)
Obstet Gynecol. 2015 Nov;126(5):e100-7. (PMID: 26488521)
Crit Care. 2020 Apr 15;24(1):148. (PMID: 32293518)
J Intensive Care Med. 2021 Feb;36(2):220-228. (PMID: 31829108)
Lancet. 2020 Mar 7;395(10226):809-815. (PMID: 32151335)
Am J Perinatol. 2020 Jun;37(8):861-865. (PMID: 32305046)
Int J Gynaecol Obstet. 2020 Jul;150(1):41-46. (PMID: 32271947)
JAMA Pediatr. 2020 Jul 1;174(7):722-725. (PMID: 32215598)
BJOG. 2020 Oct;127(11):1374-1380. (PMID: 32479682)
J Am Heart Assoc. 2020 Jul 7;9(13):e016072. (PMID: 32578471)
ASAIO J. 2020 Jul;66(7):722-730. (PMID: 32317557)
Fetal Pediatr Pathol. 2020 Jun;39(3):246-250. (PMID: 32238084)
BMJ. 2020 Jun 8;369:m2107. (PMID: 32513659)
Ultrasound Obstet Gynecol. 2020 May;55(5):586-592. (PMID: 32180292)
BMJ. 2020 May 22;369:m1923. (PMID: 32444358)
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3. (PMID: 32739398)
Obstet Gynecol. 2020 Aug;136(2):252-258. (PMID: 32433453)
Lancet. 2020 Feb 22;395(10224):e40. (PMID: 32035511)
Entry Date(s):: Date Created: 20201017 Date Completed: 20210112 Latest Revision: 20221207
Update Code:: 20240105
PubMed Central ID:: PMC7869039
DOI:: 10.1055/s-0040-1718694
PMID:: 33069171
: Czasopismo naukowe

Objective: This study aimed to describe two cases of acute respiratory distress syndrome (ARDS) secondary to novel coronavirus disease 2019 (COVID-19) in pregnant women requiring extracorporeal membrane oxygenation (ECMO), and resulting in premature delivery.
Study Design: The clinical course of two women hospitalized with ARDS due to COVID-19 care in our intensive care (ICU) is summarized; both participants provided consent to be included in this case series.
Results: Both women recovered with no clinical sequelae. Neonatal outcomes were within the realm of expected for prematurity with the exception of coagulopathy. There was no vertical transmission to the neonates.
Conclusion: This case series highlights that ECMO is a feasible treatment in the pregnant woman with severe COVID-19 and that delivery can be performed safely on ECMO with no additional risk to the fetus. While ECMO carries its natural risks, it should be considered a viable option during pregnancy and the postpartum period.
Key Points: · COVID-19 may present with a more severe course in pregnancy.. · ECMO may be used in pregnant woman with severe COVID-19.. · Delivery can be performed on ECMO without added fetal risk..
Competing Interests: None declared.
(Thieme. All rights reserved.)

Informacja